000 03766nam a22005175i 4500
001 978-0-387-69116-9
003 DE-He213
005 20161121230748.0
007 cr nn 008mamaa
008 100301s2007 xxu| s |||| 0|eng d
020 _a9780387691169
_9978-0-387-69116-9
024 7 _a10.1007/978-0-387-69116-9
_2doi
050 4 _aRC261-271
072 7 _aMJCL
_2bicssc
072 7 _aMED062000
_2bisacsh
082 0 4 _a614.5999
_223
245 1 0 _aAdvances in Molecular Oncology
_h[electronic resource] :
_bEdited under the auspices of the European Institute of Oncology (IEO) and The FIRC Institute of Molecular Oncology Foundation (IFOM) /
_cedited by Fabrizio d'Adda di Fagagna, Susanna Chiocca, Fraser McBlane, Ugo Cavallaro.
264 1 _aBoston, MA :
_bSpringer US,
_c2007.
300 _aVIII, 276 p.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 1 _aAdvances In Experimental Medicine And Biology,
_x0065-2598 ;
_v604
505 0 _aGenome Instability, Checkpoints, and the Cell Cycle -- Comparison of DNA Replication in Xenopus laevis and Simian Virus 40 -- A Genetic Screen Implicates miRNA-372 and miRNA-373 as Oncogenes in Testicular Germ Cell Tumors -- An Investigation into 53BP1 Complex Formation -- Short Abstracts – Session I -- Tumor and Microenvironment Interactions -- Tumor Promotion by Tumor-Associated Macrophages -- The AP-2a Transcription Factor Regulates Tumor Cell Migration and Apoptosis -- Modulatory Actions of Neuropeptide Y on Prostate Cancer Growth: Role of MAP Kinase/ERK 1/2 Activatio -- Short Abstracts – Session II -- Animal Models -- The Arf Tumor Suppressor in Acute Leukemias: Insights from Mouse Models of Bcr–Abl-Induced Acute Lymphoblastic Leukemia -- Short Abstracts – Session III -- Transcription and Epigenetics -- Short Abstracts – Session IV -- High-Throughput Approaches and Imaging -- Identification and Validation of the Anaplastic Large Cell Lymphoma Signature -- Cell-Cycle Inhibitor Profiling by High-Content Analysis -- Short Abstracts – Session V -- Novel Pathways and Therapeutic Targets -- Regulation for Nuclear Targeting of the Abl Tyrosine Kinase in Response to DNA Damage -- Short Abstracts – Session VI -- Poster Abstracts -- Poster Abstracts.
520 _aProceedings of the 2nd Annual IFOM-IEO Meeting on Cancer. This is a new meeting, it has about 200 attendees from Australia, Austria, Belgium, Brazil, Canada, England, France, Germany, Greece, Ireland, Italy, Japan, Netherlands, Spain, Sweden, Switzerland, and the USA. The 2nd IFOM-IEO international meeting on cancer will provide a forum in which the world’s leading cancer researchers and young scientists will discuss the latest advances in molecular oncology. The impact of recent breakthroughs in basic research and of emerging technologies on molecular medicine in cancer will be highlighted.
650 0 _aMedicine.
650 0 _aCancer research.
650 0 _aPhysical chemistry.
650 0 _aCell biology.
650 1 4 _aBiomedicine.
650 2 4 _aCancer Research.
650 2 4 _aCell Biology.
650 2 4 _aPhysical Chemistry.
700 1 _aFagagna, Fabrizio d'Adda di.
_eeditor.
700 1 _aChiocca, Susanna.
_eeditor.
700 1 _aMcBlane, Fraser.
_eeditor.
700 1 _aCavallaro, Ugo.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9780387691145
830 0 _aAdvances In Experimental Medicine And Biology,
_x0065-2598 ;
_v604
856 4 0 _uhttp://dx.doi.org/10.1007/978-0-387-69116-9
912 _aZDB-2-SBL
950 _aBiomedical and Life Sciences (Springer-11642)
999 _c503616
_d503616